Strain Information | |
---|---|
Image | |
BRC No. | RBRC03456 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | B6N.129S2-Lxn<tm1Yari>/YariRbrc |
Former Common name | Lxn KO |
H-2 Haplotype | |
ES Cell line | D3 [129S2/SvPas] |
Background strain | C57BL/6NJcl |
Appearance | |
Strain development | Developed by Yasuyoshi Arimatsu, Mitsubishi Kagaku Institute of Life Sciences. D3 ES cells were used to generate the mutant mice. The mice were backcrossed to C57BL/6N. |
Strain description | Lxn (latexin) gene knockout mice. Exon 1 of the Lxn gene was replaced with a neomycin resistant cassette. |
Colony maintenance | Heterozygote x Wild-type [C57BL/6NJcl] |
References | Reduced pain sensitivity in mice lacking latexin, an inhibitor of metallocarboxypeptidases. Jin M, Ishida M, Katoh-Fukui Y, Tsuchiya R, Higashinakagawa T, Ikegami S, Arimatsu Y Brain Res., 1075(1):117-21 (2006). 16469302 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Lxn MGI:107633 | latexin | 3 | Lxn<tm1Yari> MGI:3622076 | targeted mutation 1, Yasuyoshi Arimatsu | |||
neo | neomycin resistance gene (E. coli) | 3 | mouse phosphoglycerate kinase promoter (PGK promoter) |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | mouse phosphoglycerate kinase promoter (PGK promoter), E. coli Neomycin resistance gene, mouse Lxn genomic DNA |
Research application | |
Specific Term and Conditions | The BIOLOGICAL RESOURCE shall be used only for academic research purposes by a non-profit organization. The RECIPIENT of a non-profit organization must prior contact RIKEN BRC and negotiate with Mitsubishi Chemical Corporation to use the BIOLOGICAL RESOURCE for purposes of other than academic research. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE in relevant journals and meetings, the RECIPIENT must stipulate the source of the BIOLOGICAL RESOURCE and an acknowledgment to Mitsubishi Chemical Corporation. The RECIPIENT agrees that RIKEN BRC informs annually to Mitsubishi Chemical Corporation of RECIPIENT organization, RECIPIENT name, the specific research purpose and the date of distribution. |
Depositor | Yasuyoshi Arimatsu (Mitsubishi Kasei Institute of Life Sciences) |
Strain Status | ![]() ![]() |
Strain Availability | Recovered litters from cryopreserved sperm (2 to 4 months) Cryopreserved sperm (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
Xuchen Sun, Xuanming Chen, Yuanting Ni, Xiuzhen Li, Jiaqi Song, Jingzhu Wang, Shaohua Xu, Wei Shu, Ming Chen Latexin (LXN) enhances tumor immune surveillance in mice by inhibiting Treg cells through the macrophage exosome pathway International Journal of Biological Macromolecules 289 138822(2025) 39694381 |
He G, Ni Y, Hua R, Wan H, Tan Y, Chen Q, Xu S, Yang Y, Zhang L, Shu W, Huang KB, Mo Y, Liang H, Chen M. Latexin deficiency limits foam cell formation and ameliorates atherosclerosis by promoting macrophage phenotype differentiation. Cell Death Dis 15(10) 754(2024) 39424784 |
He G, Kan S, Xu S, Sun X, Li R, Shu W, Chen M. LXN deficiency regulates cytoskeleton remodelling by promoting proteolytic cleavage of Filamin A in vascular endothelial cells. J Cell Mol Med 25(14) 6815-6827(2021) 34085389 |